The DOI matches its Crossref record; 445 of the 445 references it cites were found in a registry or an index.
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting
Open accessAbstract
With cardiovascular disease being the leading cause of morbidity and mortality worldwide, effective and cost-efficient therapies to reduce cardiovascular risk are highly needed. Lipids and lipoprotein particles crucially contribute to atherosclerosis as underlying pathology of cardiovascular disease and influence inflammatory processes as well as function of leukocytes, vascular and cardiac cells, thereby impacting on vessels and heart. Statins form the first-line therapy with the aim to block cholesterol synthesis, but additional lipid-lowering drugs are sometimes needed to achieve low-density lipoprotein (LDL) cholesterol target values. Furthermore, beyond LDL cholesterol, also other lipid mediators contribute to cardiovascular risk. This review comprehensively discusses low- and high-density lipoprotein cholesterol, lipoprotein (a), triglycerides as well as fatty acids and derivatives in the context of cardiovascular disease, providing mechanistic insights into their role in pathological processes impacting on cardiovascular disease. Also, an overview of applied as well as emerging therapeutic strategies to reduce lipid-induced cardiovascular burden is provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 445
Kontush, A., Therond, P., Zerrad, A., Couturier, M., Négre-Salvayre, A., de Souza, J. A., Chantepie, S., & Chapman, M. J. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.145672 · Cited by 229
Roeseler, E., Julius, U., Heigl, F., Spitthoever, R., Heutling, D., Breitenberger, P., Leebmann, J., Lehmacher, W., Kamstrup, P. R., Nordestgaard, B. G., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307983 · Cited by 227
Novel Biological Functions of High-Density Lipoprotein Cholesterol
Mineo, C., & Shaul, P. W. (2012) · Circulation Research · doi:10.1161/circresaha.111.258673 · Cited by 227
Liu, P.-Y., Liu, Y.-W., Lin, L.-J., Chen, J.-H., & Liao, J. K. (2009) · Circulation · doi:10.1161/circulationaha.108.813311 · Cited by 226
Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury
Bao, W. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.12.004 · Cited by 224
Chang, J., Xie, M., Shah, V. R., Schneider, M. D., Entman, M. L., Wei, L., & Schwartz, R. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601911103 · Cited by 224
Villines, T. C., Stanek, E. J., Devine, P. J., Turco, M., Miller, M., Weissman, N. J., Griffen, L., & Taylor, A. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.017 · Cited by 223
Furlaneto, C. J., & Campa, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2143 · Cited by 223
Khera, A. V., Demler, O. V., Adelman, S. J., Collins, H. L., Glynn, R. J., Ridker, P. M., Rader, D. J., & Mora, S. (2017) · Circulation · doi:10.1161/circulationaha.116.025678 · Cited by 223
Regulation of Lipid Droplet Cholesterol Efflux From Macrophage Foam Cells
Ouimet, M., & Marcel, Y. L. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.240705 · Cited by 221
Demers, A., Samami, S., Lauzier, B., Des Rosiers, C., Sock, E. T. N., Ong, H., & Mayer, G. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.306032 · Cited by 221
Hattori, T., Shimokawa, H., Higashi, M., Hiroki, J., Mukai, Y., Tsutsui, H., Kaibuchi, K., & Takeshita, A. (2004) · Circulation · doi:10.1161/01.cir.0000127939.16111.58 · Cited by 219
Raal, F. J., Giugliano, R. P., Sabatine, M. S., Koren, M. J., Blom, D., Seidah, N. G., Honarpour, N., Lira, A., Xue, A., Chiruvolu, P., et al. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101063 · Cited by 218
Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins
Jonas, A. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90062-m · Cited by 214
Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes
Russo, S. B., Baicu, C. F., Van Laer, A., Geng, T., Kasiganesan, H., Zile, M. R., & Cowart, L. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63888 · Cited by 211
Stroes, E. S., Nierman, M. C., Meulenberg, J. J., Franssen, R., Twisk, J., Henny, C. P., Maas, M. M., Zwinderman, A. H., Ross, C., Aronica, E., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.175620 · Cited by 209
HDL and ApoA Prevent Cell Death of Endothelial Cells Induced by Oxidized LDL
Suc, I., Escargueil-Blanc, I., Troly, M., Salvayre, R., & Nègre-Salvayre, A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.2158 · Cited by 204
Knapp, H. H., Schrott, H., Ma, P., Knopp, R., Chin, B., Gaziano, J. M., Donovan, J. M., Burke, S. K., & Davidson, M. H. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00638-6 · Cited by 203
Wu, J. H. Y., Lemaitre, R. N., King, I. B., Song, X., Psaty, B. M., Siscovick, D. S., & Mozaffarian, D. (2014) · Circulation · doi:10.1161/circulationaha.114.011590 · Cited by 202
Impact of HMG CoA reductase inhibition on small GTPases in the heart
Laufs, U. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00540-5 · Cited by 202
The HDL proteome in acute coronary syndromes shifts to an inflammatory profile
Alwaili, K., Bailey, D., Awan, Z., Bailey, S. D., Ruel, I., Hafiane, A., Krimbou, L., Laboissiere, S., & Genest, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.07.013 · Cited by 201
Wu, Z., Wagner, M. A., Zheng, L., Parks, J. S., Shy, J. M., Smith, J. D., Gogonea, V., & Hazen, S. L. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1284 · Cited by 201
Calkin, A. C., Drew, B. G., Ono, A., Duffy, S. J., Gordon, M. V., Schoenwaelder, S. M., Sviridov, D., Cooper, M. E., Kingwell, B. A., & Jackson, S. P. (2009) · Circulation · doi:10.1161/circulationaha.109.870709 · Cited by 200
Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux.
Banka, C. L., Yuan, T., de Beer, M. C., Kindy, M., Curtiss, L. K., & de Beer, F. C. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39863-1 · Cited by 197
Lima, J. A. C., Desai, M. Y., Steen, H., Warren, W. P., Gautam, S., & Lai, S. (2004) · Circulation · doi:10.1161/01.cir.0000145170.22652.51 · Cited by 196
Chan, K. L., Pillon, N. J., Sivaloganathan, D. M., Costford, S. R., Liu, Z., Théret, M., Chazaud, B., & Klip, A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.646992 · Cited by 195
Shao, B., Tang, C., Sinha, A., Mayer, P. S., Davenport, G. D., Brot, N., Oda, M. N., Zhao, X.-Q., & Heinecke, J. W. (2014) · Circulation Research · doi:10.1161/circresaha.114.303454 · Cited by 195
Shimokawa, H., Hiramori, K., Iinuma, H., Hosoda, S., Kishida, H., Osada, H., Katagiri, T., Yamauchi, K., Yui, Y., Minamino, T., et al. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200211000-00013 · Cited by 193
Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease
Sattler, K. J. E., Elbasan, Ş., Keul, P., Elter-Schulz, M., Bode, C., Gräler, M. H., Bröcker-Preuss, M., Budde, T., Erbel, R., Heusch, G., et al. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0112-5 · Cited by 191
High-density lipoprotein as a modulator of platelet and coagulation responses
van der Stoep, M., Korporaal, S. J. A., & Van Eck, M. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu137 · Cited by 191
Über den Gehalt normaler und atheromatöser Aorten an Cholesterin und Cholesterinestern.
Windaus, A. (1910) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1910.67.2.174 · Cited by 184
Oligonucleotide Therapeutics — A New Class of Cholesterol-Lowering Drugs
Khvorova, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1614154 · Cited by 183
Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via Inhibition of Nox2
Pignatelli, P., Carnevale, R., Pastori, D., Cangemi, R., Napoleone, L., Bartimoccia, S., Nocella, C., Basili, S., & Violi, F. (2012) · Circulation · doi:10.1161/circulationaha.112.095554 · Cited by 182
Tsai, M. Y., Steffen, B. T., Guan, W., McClelland, R. L., Warnick, R., McConnell, J., Hoefner, D. M., & Remaley, A. T. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302401 · Cited by 182
Brewer, H. B., Remaley, A. T., Neufeld, E. B., Basso, F., & Joyce, C. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000142804.27420.5b · Cited by 182
Ruuth, M., Nguyen, S. D., Vihervaara, T., Hilvo, M., Laajala, T. D., Kondadi, P. K., Gisterå, A., Lähteenmäki, H., Kittilä, T., Huusko, J., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy319 · Cited by 180
de Oliveira Otto, M. C., Wu, J. H. Y., Baylin, A., Vaidya, D., Rich, S. S., Tsai, M. Y., Jacobs, D. R., & Mozaffarian, D. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000506 · Cited by 180
Akdim, F., Visser, M. E., Tribble, D. L., Baker, B. F., Stroes, E. S. G., Yu, R., Flaim, J. D., Su, J., Stein, E. A., & Kastelein, J. J. P. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.003 · Cited by 179
Sattler, K., & Levkau, B. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp070 · Cited by 174
Marathe, G. K., Zimmerman, G. A., & McIntyre, T. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211126200 · Cited by 173
Mertens, A., Verhamme, P., Bielicki, J. K., Phillips, M. C., Quarck, R., Verreth, W., Stengel, D., Ninio, E., Navab, M., Mackness, B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000056523.08033.9f · Cited by 172
Pelat, M., Dessy, C., Massion, P., Desager, J.-P., Feron, O., & Balligand, J.-L. (2003) · Circulation · doi:10.1161/01.cir.0000065601.83526.3e · Cited by 171
Serum amyloid A impairs the antiinflammatory properties of HDL
Han, C. Y., Tang, C., Guevara, M. E., Wei, H., Wietecha, T., Shao, B., Subramanian, S., Omer, M., Wang, S., O’Brien, K. D., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83475 · Cited by 171
Shao, B., Pennathur, S., & Heinecke, J. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337345 · Cited by 170
Sacks, F. M. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000146 · Cited by 168
He, K., Liu, K., Daviglus, M. L., Jenny, N. S., Mayer-Davis, E., Jiang, R., Steffen, L., Siscovick, D., Tsai, M., & Herrington, D. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.016 · Cited by 168
Carpentier, A. C., Frisch, F., Labbé, S. M., Gagnon, R., de Wal, J., Greentree, S., Petry, H., Twisk, J., Brisson, D., & Gaudet, D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3002 · Cited by 165
Compromised LCAT Function Is Associated With Increased Atherosclerosis
Hovingh, G. K., Hutten, B. A., Holleboom, A. G., Petersen, W., Rol, P., Stalenhoef, A., Zwinderman, A. H., de Groot, E., Kastelein MD, J. J. P., & Kuivenhoven, J. A. (2005) · Circulation · doi:10.1161/circulationaha.105.540427 · Cited by 165
Duncan, M. S., Vasan, R. S., & Xanthakis, V. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011433 · Cited by 164
Adam, O., Lavall, D., Theobald, K., Hohl, M., Grube, M., Ameling, S., Sussman, M. A., Rosenkranz, S., Kroemer, H. K., Schäfers, H.-J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.064 · Cited by 163
Omura, M., Kobayashi, S., Mizukami, Y., Mogami, K., Todoroki-Ikeda, N., Miyake, T., & Matsuzaki, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02351-6 · Cited by 162
ANGINA PECTORIS IN HEREDITARY XANTHOMATOSIS
MÜLLER, C. (1939) · Archives of Internal Medicine · doi:10.1001/archinte.1939.00190040016002 · Cited by 162
Akdim, F., Stroes, E. S. G., Sijbrands, E. J. G., Tribble, D. L., Trip, M. D., Jukema, J. W., Flaim, J. D., Su, J., Yu, R., Baker, B. F., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.069 · Cited by 162
Ference, B. A., Cannon, C. P., Landmesser, U., Lüscher, T. F., Catapano, A. L., & Ray, K. K. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx450 · Cited by 161
Tölle, M., Pawlak, A., Schuchardt, M., Kawamura, A., Tietge, U. J. F., Lorkowski, S., Keul, P., Assmann, G., Chun, J. J. M., Levkau, B., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.161042 · Cited by 160
Familial hypobetalipoproteinemia: genetics and metabolism
Schonfeld, G., Lin, X., & Yue, P. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4473-0 · Cited by 159
The composition and metabolism of large and small LDL
Diffenderfer, M. R., & Schaefer, E. J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000067 · Cited by 159
Increased de novo ceramide synthesis and accumulation in failing myocardium
Ji, R., Akashi, H., Drosatos, K., Liao, X., Jiang, H., Kennel, P. J., Brunjes, D. L., Castillero, E., Zhang, X., Deng, L. Y., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.96203 · Cited by 159
N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation
Joffre, C., Rey, C., & Layé, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01022 · Cited by 159
Ostos, M. A., Conconi, M., Vergnes, L., Baroukh, N., Ribalta, J., Girona, J., Caillaud, J.-M., Ochoa, A., & Zakin, M. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.1023 · Cited by 158
Ray, K. K., Stoekenbroek, R. M., Kallend, D., Leiter, L. A., Landmesser, U., Wright, R. S., Wijngaard, P., & Kastelein, J. J. P. (2018) · Circulation · doi:10.1161/circulationaha.118.034710 · Cited by 154
Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk
Zewinger, S., Drechsler, C., Kleber, M. E., Dressel, A., Riffel, J., Triem, S., Lehmann, M., Kopecky, C., Säemann, M. D., Lepper, P. M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv352 · Cited by 153
Omega-6 fats for the primary and secondary prevention of cardiovascular disease
Hooper, L., Al-Khudairy, L., Abdelhamid, A. S., Rees, K., Brainard, J. S., Brown, T. J., Ajabnoor, S. M., O'Brien, A. T., Winstanley, L. E., Donaldson, D. H., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011094.pub3 · Cited by 153
A gift from nature: the birth of the statins
Endo, A. (2008) · Nature Medicine · doi:10.1038/nm1008-1050 · Cited by 152
Lamon‐Fava, S., Diffenderfer, M. R., Barrett, P. H. R., Buchsbaum, A., Nyaku, M. K., Horvath, K. V., Asztalos, B. F., Otokozawa, S., Ai, M., Matthan, N. R., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.164541 · Cited by 150
Phospholipase A2 enzymes and the risk of atherosclerosis
Rosenson, R. S., & Hurt‐Camejo, E. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs148 · Cited by 147
Re, D. P. D., Miyamoto, S., & Brown, J. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m604298200 · Cited by 145
Thompson, P. D., MacDougall, D. E., Newton, R. S., Margulies, J. R., Hanselman, J. C., Orloff, D. G., McKenney, J. M., & Ballantyne, C. M. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.12.025 · Cited by 145
Blom, D. J., Averna, M. R., Meagher, E. A., Theron, H. D. T., Sirtori, C. R., Hegele, R. A., Shah, P. K., Gaudet, D., Stefanutti, C., Vigna, G. B., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.028208 · Cited by 144
Tölle, M., Huang, T., Schuchardt, M., Jankowski, V., Prüfer, N., Jankowski, J., Tietge, U. J. F., Zidek, W., & van der Giet, M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs089 · Cited by 143
Self-citationInhibition of Arterial Thrombus Formation by ApoA1 Milano
Li, D., Weng, S., Yang, B., Zander, D. S., Saldeen, T. G. P., Nichols, W. W., Khan, S. R., & Mehta, J. L. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.378 · Cited by 143
Oxidized low‐density lipoprotein in inflammation‐driven thrombosis
Obermayer, G., Afonyushkin, T., & Binder, C. J. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13925 · Cited by 141
Dong, Z., Wu, T., Qin, W., An, C., Wang, Z., Zhang, M., Zhang, Y., Zhang, C., & An, F. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00186 · Cited by 139
Miyahara, T., Runge, S. J., Chatterjee, A., Chen, M., Mottola, G., Fitzgerald, J. M., Serhan, C. N., & Conte, M. S. (2013) · The FASEB Journal · doi:10.1096/fj.12-225615 · Cited by 138
Discontinuation of statin therapy following an acute myocardial infarction: a population-based study
Daskalopoulou, S. S., Delaney, J. A., Filion, K. B., Brophy, J. M., Mayo, N. E., & Suissa, S. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn346 · Cited by 135
Yamauchi, Y., Hayashi, M., Abe-Dohmae, S., & Yokoyama, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306258200 · Cited by 134
Wyler von Ballmoos, M. C., Haring, B., & Sacks, F. M. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.05.002 · Cited by 134
Leukotriene Signaling in Atherosclerosis and Ischemia
Bäck, M. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6140-9 · Cited by 134
Duell, P. B., Santos, R. D., Kirwan, B., Witztum, J. L., Tsimikas, S., & Kastelein, J. J. P. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.04.013 · Cited by 134
Omega-6 fats for the primary and secondary prevention of cardiovascular disease
Hooper, L., Al-Khudairy, L., Abdelhamid, A. S., Rees, K., Brainard, J. S., Brown, T. J., Ajabnoor, S. M., O'Brien, A. T., Winstanley, L. E., Donaldson, D. H., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011094.pub4 · Cited by 133
Annema, W., & Tietge, U. J. F. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0175-2 · Cited by 133
Antiplatelet Actions of Statins and Fibrates Are Mediated by PPARs
Ali, F. Y., Armstrong, P. C. J., Dhanji, A., Tucker, A. T., Paul‐Clark, M. J., Mitchell, J. A., & Warner, T. D. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.183160 · Cited by 133
Fogacci, F., Ferri, N., Toth, P. P., Ruscica, M., Corsini, A., & Cicero, A. F. G. (2019) · Drugs · doi:10.1007/s40265-019-01114-z · Cited by 132
The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases
Park, S., Mathis, K. W., & Lee, I. K. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9275-3 · Cited by 132
Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages
Adorni, M. P., Cipollari, E., Favari, E., Zanotti, I., Zimetti, F., Corsini, A., Ricci, C., Bernini, F., & Ferri, N. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.019 · Cited by 130
Secretory group II phospholipase A2 in human atherosclerotic plaques
Menschikowski, M., Kasper, M. E., Lattke, P., Schiering, A., Schiefer, S., Stockinger, H., & Jaroß, W. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05604-1 · Cited by 130
Ye, D., Lammers, B., Zhao, Y., Meurs, I., van Berkel, T. J. C., & Eck, M. V. (2011) · Current Drug Targets · doi:10.2174/138945011795378522 · Cited by 129
Lauring, B. P., Taggart, A. K. P., Tata, J. R., Dunbar, R. L., Caro, L., Cheng, K., Chin, J., Colletti, S. L., Côté, J., Khalilieh, S. G., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003877 · Cited by 128
Ribas, V., Sánchez‐Quesada, J. L., Antón, R. I., Camacho, M., Julve, J., Escolá‐Gil, J. C., Vila, L., Ordóñez‐Llanos, J., & Blanco‐Vaca, F. (2004) · Circulation Research · doi:10.1161/01.res.0000146031.94850.5f · Cited by 127
Kishi, T., Hirooka, Y., Masumoto, A., Ito, K., Kimura, Y., Inokuchi, K., Tagawa, T., Shimokawa, H., Takeshita, A., & Sunagawa, K. (2005) · Circulation · doi:10.1161/circulationaha.104.510248 · Cited by 126
Porter, K. E. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.032 · Cited by 124
Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia
Akdim, F., Tribble, D. L., Flaim, J., Yu, R. Z., Su, J. Q., Geary, R. S., Baker, B. F., Fuhr, R., Wedel, M. K., & Kastelein, J. J. P. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr148 · Cited by 123
Toward Immunomodulatory and Anti-Inflammatory Properties of Statins
Arnaud, C., Braunersreuther, V., & Mach, F. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.07.002 · Cited by 123
Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL
Elsøe, S., Ahnström, J., Christoffersen, C., Hoofnagle, A. N., Plomgaard, P., Heinecke, J. W., Binder, C. J., Björkbacka, H., Dahlbäck, B., & Nielsen, L. B. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.031 · Cited by 121
Abdurrachim, D., Luiken, J. J. F. P., Nicolay, K., Glatz, J. F. C., Prompers, J. J., & Nabben, M. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv105 · Cited by 120
Mallat, Z., Steg, P. G., Bénessiano, J., Tanguy, M., Fox, K. A. A., Collet, J., Dabbous, O. H., Henry, P., Carruthers, K. F., Dauphin, A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.056 · Cited by 119
Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9
German, C. A., & Shapiro, M. D. (2019) · BioDrugs · doi:10.1007/s40259-019-00399-6 · Cited by 118
Allahyari, A., Jernberg, T., Hagström, E., Leósdóttir, M., Lundman, P., & Ueda, P. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa034 · Cited by 118
Kosoglou, T., Meyer, I., Veltri, E. P., Statkevich, P., Yang, B., Zhu, Y., Mellars, L., Maxwell, S. E., Patrick, J. E., Cutler, D. L., et al. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01633.x · Cited by 117
Inherited disorders of HDL metabolism and atherosclerosis
Hovingh, G. K., de Groot, E., van der Steeg, W. A., Boekholdt, S. M., Hutten, B. A., Kuivenhoven, J. A., & Kastelein, J. J. P. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000162318.47172.ef · Cited by 115
Serum Amyloid A and Lipoprotein Retention in Murine Models of Atherosclerosis
O’Brien, K. D., McDonald, T. O., Kunjathoor, V. V., Eng, K., Knopp, E. A., Lewis, K., Lopez, R., Kirk, E. A., Chait, A., Wight, T. N., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000158383.65277.2b · Cited by 115
Novel Function of Lecithin-Cholesterol Acyltransferase
Goyal, J., Wang, K., Liu, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16231 · Cited by 114
Jensen, M. K., Aroner, S. A., Mukamal, K. J., Furtado, J. D., Post, W. S., Tsai, M. Y., Tjønneland, A. M., Polak, J. F., Rimm, E. B., Overvad, K., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.031276 · Cited by 114
The versatility of HDL: a crucial anti‐inflammatory regulator
Säemann, M. D., Poglitsch, M., Kopecky, C., Haidinger, M., Hörl, W. H., & Weichhart, T. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02361.x · Cited by 113
Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling
Dell’Italia, L. J., Collawn, J. F., & Ferrario, C. M. (2018) · Circulation Research · doi:10.1161/circresaha.117.310978 · Cited by 113
Yamada, H., Yoshida, M., Nakano, Y., Suganami, T., Satoh, N., Mita, T., Azuma, K., Itoh, M., Yamamoto, Y., Kamei, Y., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.171736 · Cited by 112
Rudling, M. J., Reihnér, E., Einarsson, K., Ewerth, S., & Angelin, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3469 · Cited by 112
Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells
Oi, S., Haneda, T., Osaki, J., Kashiwagi, Y., Nakamura, Y., Kawabe, J.-I., & Kikuchi, K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00282-4 · Cited by 111
Meyers, C. D., Tremblay, K., Amer, A., Chen, J., Jiang, L., & Gaudet, D. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0006-5 · Cited by 110
Robinson, J. G., Williams, K. J., Gidding, S. S., Borén, J., Tabas, I. A., Fisher, E. A. A., Packard, C. J., Pencina, M. J., Fayad, Z. A., Mani, V., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009778 · Cited by 110
Zewinger, S., Kleber, M. E., Tragante, V., McCubrey, R. O., Schmidt, A. F., Direk, K., Laufs, U., Werner, C. M., Köenig, W., Rothenbacher, D., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30096-7 · Cited by 109
Cholesterol and Atherosclerotic Cardiovascular Disease: A Lifelong Problem
Gidding, S. S., & Allen, N. B. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012924 · Cited by 109
Christison, J. K., Rye, K., & Stocker, R. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41119-8 · Cited by 107
Akagi, D., Chen, M., Toy, R., Chatterjee, A., & Conte, M. S. (2015) · The FASEB Journal · doi:10.1096/fj.14-265363 · Cited by 106
Denison, H., Nilsson, C., Löfgren, L., Himmelmann, A., Mårtensson, G., Knutsson, M., AL‐Shurbaji, A., Tornqvist, H., & Eriksson, J. W. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12221 · Cited by 104
Davidson, M. H., Toth, P. D., Weiss, S. R., McKenney, J. M., Hunninghake, D., Isaacsohn, J. L., Donovan, J. M., & Burke, S. K. (2001) · Clinical Cardiology · doi:10.1002/clc.4960240610 · Cited by 103
Lipoprotein(a): New insights into mechanisms of atherogenesis and thrombosis
Deb, A., & Caplice, N. M. (2004) · Clinical Cardiology · doi:10.1002/clc.4960270503 · Cited by 99
Kosuge, M., Ebina, T., Ishikawa, T., Hibi, K., Tsukahara, K., Okuda, J., Iwahashi, N., Ozaki, H., Yano, H., Kusama, I., et al. (2007) · Circulation Journal · doi:10.1253/circj.71.186 · Cited by 95
Liu, T., Xiang, A., Peng, T., Doran, A. C., Tracey, K. J., Barnes, B. J., Tabas, I. A., Son, M., & Diamond, B. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907490116 · Cited by 95
Kai, H., Muraishi, A., Sugiu, Y., Nishi, H., Seki, Y., Kuwahara, F., Kimura, A., Kato, H., & Imaizumi, T. (1998) · Circulation Research · doi:10.1161/01.res.83.6.594 · Cited by 94
Raffaï, R. L., Loeb, S. M., & Weisgraber, K. H. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000152613.83243.12 · Cited by 94
Karagiannis, A. D., Liu, M., Toth, P. P., Zhao, S., Agrawal, D. K., Libby, P., & Chatzizisis, Y. S. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0718-x · Cited by 94
Goldenberg, J. R., Carley, A. N., Ji, R., Zhang, X., Fasano, M. J., Schulze, P. C., & Lewandowski, E. D. (2019) · Circulation · doi:10.1161/circulationaha.119.039610 · Cited by 94
Coassin, S., Erhart, G., Weissensteiner, H., Eca Guimarães de Araújo, M., Lamina, C., Schönherr, S., Forer, L., Haun, M., Losso, J. L., Köttgen, A., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx174 · Cited by 93
Structural properties of the microsomal triglyceride-transfer protein complex
Wetterau, J. R., Aggerbeck, L. P., Laplaud, P. M., & McLean, L. R. (1991) · Biochemistry · doi:10.1021/bi00232a006 · Cited by 93
LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins
Wei, W., Li, X., Feng, Q., Kubo, M., Kullo, I. J., Peissig, P. L., Karlson, E. W., Jarvik, G. P., Lee, M. T. M., Shang, N., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.031356 · Cited by 93
Rinne, P., Guillamat‐Prats, R., Rami, M., Bîndilă, L., Ring, L., Lyytikäinen, L., Raitoharju, E., Oksala, N., Lehtimäki, T. J., Weber, C., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311185 · Cited by 93
Girotti, A. W. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.004 · Cited by 92
Vohl, M., Neville, T. A.-M., Kumarathasan, R., Braschi, S., & Sparks, D. L. (1999) · Biochemistry · doi:10.1021/bi982258w · Cited by 92
AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation
Lepropre, S., Kautbally, S., Octave, M., Ginion, A., Onselaer, M.-B., Steinberg, G. R., Kemp, B. E., Hego, A., Wéra, O., Brouns, S. L. N., et al. (2018) · Blood · doi:10.1182/blood-2018-02-831503 · Cited by 92
Highlighting Residual Atherosclerotic Cardiovascular Disease Risk
Matsuura, Y., Kanter, J. E., & Bornfeldt, K. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311999 · Cited by 91
Gencer, B., Mach, F., Murphy, S. A., Ferrari, G. M. D., Huber, K., Lewis, B. S., Ferreira, J., Kurtz, C. E., Wang, H., Honarpour, N., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0882 · Cited by 91
Ross, S., D’Mello, M., Anand, S. S., Eikelboom, J., CARDIoGRAMplusC4D Consortium*, Stewart, A. F. R., Samani, N. J., Roberts, R., & Paré, G. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000952 · Cited by 90
Davidsson, P., Hulthe, J., Fagerberg, B., Olsson, B., Hallberg, C., Dahllöf, B., & Camejo, G. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500161-jlr200 · Cited by 90
Interplay Between SAFE and RISK Pathways in Sphingosine-1-Phosphate–Induced Cardioprotection
Somers, S., Frias, M. A., Lacerda, L., Opie, L. H., & Lecour, S. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6376-2 · Cited by 90
A brief elevation of serum amyloid A is sufficient to increase atherosclerosis
Thompson, J. C., Jayne, C., Thompson, J., Wilson, P. G., Yoder, M. H., Webb, N. R., & Tannock, L. R. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m054015 · Cited by 90
Pruzanski, W., Stefanski, E., de Beer, F. C., de Beer, M. C., Vadas, P., Ravandi, A., & Kuksis, A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32470-6 · Cited by 90
High-Density Lipoproteins Induce Transforming Growth Factor-β 2 Expression in Endothelial Cells
Norata, G. D., Callegari, E., Marchesi, M., Chiesa, G., Eriksson, P. O., & Catapano, A. L. (2005) · Circulation · doi:10.1161/circulationaha.104.472886 · Cited by 88
Serum amyloid A3 is pro-atherogenic
Thompson, J. C., Wilson, P. G., Shridas, P., Ji, A., de Beer, M. C., de Beer, F. C., Webb, N. R., & Tannock, L. R. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.11.011 · Cited by 88
Lopategi, A., Flores-Costa, R., Rius, B., López-Vicario, C., Alcaraz-Quiles, J., Titos, E., & Clària, J. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3hi0517-206rr · Cited by 87
Cardiolipotoxicity, Inflammation, and Arrhythmias: Role for Interleukin-6 Molecular Mechanisms
Alì, A., Boutjdir, M., & Aromolaran, A. S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01866 · Cited by 87
Hofmann, U., Burkard, N., Vogt, C., Thoma, A., Frantz, S., Ertl, G., Ritter, O., & Bonz, A. W. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp137 · Cited by 85
Shridas, P., de Beer, M. C., & Webb, N. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002428 · Cited by 85
Hua, S., Song, C., Geczy, C. L., Freedman, B., & Witting, P. K. (2009) · Redox Report · doi:10.1179/135100009x12525712409490 · Cited by 84
Pro-resolving lipid mediators in vascular disease
Conte, M. S., Desai, T. A., Wu, B., Schaller, M. S., & Werlin, E. C. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97947 · Cited by 84
Varbo, A., & Nordestgaard, B. G. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.310269 · Cited by 83
Pruzanski, W., LAMBEAU, L., Lazdunski, M., Cho, W., Kopilov, J., & Kuksis, A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.07.005 · Cited by 83
Ghesquiere, S. A. I., Gijbels, M. J., Anthonsen, M. W., van Gorp, P. J., van der Made, I., Johansen, B., Hofker, M. H., & de Winther, M. P. J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400253-jlr200 · Cited by 82
Gisterå, A., Klement, M. L., Polyzos, K. A., Mailer, R. K., Duhlin, A., Karlsson, M. C. I., Ketelhuth, D. F. J., & Hansson, G. K. (2018) · Circulation · doi:10.1161/circulationaha.118.034076 · Cited by 82
Custodis, F., EBERL, M., Kilter, H., Böhm, M., & Laufs, U. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.04.005 · Cited by 81
Kain, V., Liu, F., Kozlovskaya, V., Ingle, K. A., Bolisetty, S., Agarwal, A., Khedkar, S. A., Prabhu, S. D., Kharlampieva, E., & Halade, G. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-10441-8 · Cited by 81
Ng, D. S., Chu, T., Esposito, B., Hui, P., Connelly, P. W., & Gross, P. L. (2007) · Cardiovascular Pathology · doi:10.1016/j.carpath.2007.10.001 · Cited by 80
Rawlings, R. H., Nohria, A., Liu, P., Donnelly, J., Creager, M. A., Ganz, P., Selwyn, A. P., & Liao, J. K. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.10.008 · Cited by 79
Liu, L., Trent, C. M., Fang, X., Son, N.-H., Jiang, H., Blaner, W. S., Hu, Y., Yin, Y., Farese, R. V., Homma, S., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.601864 · Cited by 76
Post‐transcriptional control of negative acute phase genes by transforming growth factor beta.
Morrone, G., Cortese, R., & Sorrentino, V. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08553.x · Cited by 74
Ostad, M. A., Eggeling, S., Tschentscher, P., Schwedhelm, E., Böger, R. H., Wenzel, P., Meinertz, T., Münzel, T. F., & Warnholtz, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.032 · Cited by 74
Campos, H., Perlov, D., Khoo, C., & Sacks, F. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31574-1 · Cited by 73
Sartipy, P., Johansen, B., Gåsvik, K., & Hurt‐Camejo, E. (2000) · Circulation Research · doi:10.1161/01.res.86.6.707 · Cited by 72
Zhao, Y., Ma, Y., Fang, Y., Liu, L., Wu, S., Fu, D., & Wang, X. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.09.018 · Cited by 71
ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice
Shi, J., Zhang, Y.-W., Yu, Y., Zhang, L., & Wei, L. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.08.008 · Cited by 71
Activation of autophagy in macrophages by pro-resolving lipid mediators
Prieto, P., Rosales-Mendoza, C. E., TerrÓn, V., Toledano, V., Cuadrado, A., LÓpez-Collazo, E., Bannenberg, G., Martín-Sanz, P., FernÁndez-Velasco, M., & BoscÁ, L. (2015) · Autophagy · doi:10.1080/15548627.2015.1078958 · Cited by 71
Scheffer, P. G., Teerlink, T., Dekker, J. M., Bos, G., Nijpels, G., Diamant, M., Kostense, P. J., Stehouwer, C. D. A., & Heine, R. J. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.103234 · Cited by 71
Kriska, T., Marathe, G. K., Schmidt, J. C., McIntyre, T. M., & Girotti, A. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608135200 · Cited by 70
Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes.
Pruzanski, W., Vadas, P., & Browning, J. L. (1993) · PubMed · Cited by 69
Cazita, P. M., Barbeiro, D. F., Moretti, A. I. S., Quintão, E. C. R., & Soriano, F. G. (2008) · Shock · doi:10.1097/shk.0b013e31816e30fd · Cited by 67
Croyal, M., Ouguerram, K., Passard, M., Ferchaud‐Roucher, V., Chétiveaux, M., Billon‐Crossouard, S., de Gouville, A., Lambert, G. C., Krempf, M., & Nobécourt, E. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305835 · Cited by 65
Nishikido, T., & Ray, K. K. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00199 · Cited by 65
Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions
Yamada, T., Kakihara, T., Kamishima, T., Fukuda, T., & Kawai, T. (1996) · Pathology International · doi:10.1111/j.1440-1827.1996.tb03552.x · Cited by 64
Rached, F. H., Lhomme, M., Camont, L., Gomes, F. L. T., Dauteuille, C., Robillard, P., Santos, R. D., Lesnik, P., Junior, C. V. S., Chapman, M. J., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.05.007 · Cited by 61
Arsenault, B. J., Petrides, F., Tabet, F., Bao, W., Hovingh, G. K., Boekholdt, S. M., Ramin‐Mangata, S., Meilhac, O., DeMicco, D. A., Rye, K., et al. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.10.001 · Cited by 61
Simvastatin Attenuates Cardiac Fibrosis via Regulation of Cardiomyocyte-Derived Exosome Secretion
Kuo, H., Hsieh, C., Wang, S., Chang, C.-Y., Hung, C., Kuo, P., Liu, Y., Li, C., & Liu, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060794 · Cited by 61
Rallidis, L. S., Tellis, C. C., Lekakis, J. P., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.057 · Cited by 60
Li, M., Liu, Y., Dutt, P., Fanburg, B. L., & Toksoz, D. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00133.2007 · Cited by 60
Intravenous clusterin administration reduces myocardial infarct size in rats
van Dijk, A., Vermond, R. A., Krijnen, P. A. J., Juffermans, L. J. M., Hahn, N. E., Makker, S. P., Aarden, L. A., Hack, E., Spreeuwenberg, M. D., van Rossum, B. C., et al. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02345.x · Cited by 60
Lipid-lowering effects of colesevelam HCl in combination with ezetimibe
Bays, H. E., Rhyne, J. M., Abby, S. L., Lai, Y., & Jones, M. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x148436 · Cited by 58
Wang, X., & Musunuru, K. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.05.008 · Cited by 58
RISK and SAFE Signaling Pathway Involvement in Apolipoprotein A-I-Induced Cardioprotection
Kalakech, H., Hibert, P., Mirebeau‐Prunier, D., Tamareille, S., Letournel, F., Macchi, L., Pinet, F., Furber, A., & Prunier, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107950 · Cited by 57
Quantitative Assessment of the Influence of Paraoxonase 1 Activity and Coronary Heart Disease Risk
Wang, M., Lang, X., Cui, S., Zou, L.-J., Cao, J., Wang, S., & Wu, X.-T. (2012) · DNA and Cell Biology · doi:10.1089/dna.2011.1478 · Cited by 56
Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome
Gomaraschi, M., Ossoli, A., Favari, E., Adorni, M. P., Sinagra, G., Cattin, L., Veglia, F., Bernini, F., Franceschini, G., & Calabresi, L. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt169 · Cited by 55
HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity
Frias, M. A., Pedretti, S., Hacking, D., Somers, S., Lacerda, L., Opie, L. H., James, R. W., & Lecour, S. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.02.003 · Cited by 54
Lack of Protection against Oxidative Modification of LDL by Avian HDL
Mackness, B., Durrington, P. N., & Mackness, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8803 · Cited by 51
Ren, K., Tang, Z., Jiang, Y., Tan, Y., & Yi, G. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.03.038 · Cited by 51
Asselbergs, F. W., Williams, S. M., Hebert, P. R., Coffey, C. S., Hillege, H. L., Navis, G. J., Vaughan, D. E., van Gilst, W. H., & Moore, J. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02311.x · Cited by 50
Emerging roles for phospholipid transfer protein in lipid and lipoprotein metabolism
Albers, J. J., & Cheung, M. C. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200406000-00004 · Cited by 50
Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction
Sposito, A. C., Júnior, J. C. D. L., Moura, F. A., Barreto, J., Bonilha, I., Santana, M., Virginio, V. W., Sun, L., de Carvalho, L. S. F., Soares, A., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312880 · Cited by 49
Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin
Pesaro, A. E. P., Junior, C. V. S., Fernandes, J. L., Cavalcanti, A. B., Campos, A. H., Martins, H. S., Maranhão, R. C., de Lemos, J. A., de Souza, H. P., & Nicolau, J. C. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.01.062 · Cited by 48
Meyers, C. D., Amer, A., Majumdar, T., & Chen, J. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.509 · Cited by 47
Blom, D. J., Fayad, Z. A., Kastelein, J. J. P., Larrey, D. G., Makris, L., Schwamlein, C., Bloeden, L., & Underberg, J. A. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.11.011 · Cited by 47
Karalis, I. K., & Jukema, J. W. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1004-9 · Cited by 47
Stefanutti, C., Blom, D. J., Averna, M. R., Meagher, E. A., Theron, H. D. T., Marais, A. D., Hegele, R. A., Sirtori, C. R., Shah, P. K., Gaudet, D., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.014 · Cited by 46
Chan, G. K. L., Witkowski, A., Gantz, D., Zhang, T. O., Zanni, M. T., Jayaraman, S., & Cavigiolio, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.630442 · Cited by 45
Vilahur, G., Casaní, L., Peña, E., Durán, X., Juan‐Babot, O., & Badimón, L. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.02.009 · Cited by 45
O’Connell, R. P., Musa, H., Gomez, M. S. M., Avula, U. M. R., Herron, T. J., Kalifa, J., & ANUMONWO, J. M. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133052 · Cited by 44
Filipovic, M. G., Aeschbacher, S., Reiner, M. F., Stivala, S., Gobbato, S., Bonetti, N. R., Risch, M., Risch, L., Camici, G. G., Lüscher, T. F., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001728 · Cited by 44
Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currents
Haim, T. E., Wang, W., Flagg, T. P., Tones, M. A., Bahinski, A., Numann, R. E., Nichols, C. G., & Nerbonne, J. M. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.10.004 · Cited by 42
Öörni, K., & Kovanen, P. T. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832fa14d · Cited by 42
The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodies
Lambert, G. C., Thedrez, A., Croyal, M., Ramin‐Mangata, S., Couret, D., Diotel, N., Nobécourt, E., Krempf, M., LeBail, J. C., Poirier, B., et al. (2017) · Clinical Science · doi:10.1042/cs20160403 · Cited by 42
Palmitoylation: A Fatty Regulator of Myocardial Electrophysiology
Essandoh, K., Philippe, J. M., Jenkins, P. M., & Brody, M. J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00108 · Cited by 42
Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients
Bounafaa, A., Berrougui, H., Ikhlef, S., Essamadi, A., Nasser, B., Bennis, A., Yamoul, N., Ghalim, N., & Khalil, A. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.09.001 · Cited by 41
Cited by
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
Signaling pathways of chronic kidney diseases, implications for therapeutics
Yuan, Q., Tang, B., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01036-5 · Cited by 453
Ketogenic diet and multiple health outcomes: an umbrella review of meta-analysis
Chen, S., Su, X., Feng, Y., Li, R., Liao, M., Fan, L., Liu, J., Chen, S., Zhang, S., Cai, J., et al. (2023) · Nutrients · doi:10.3390/nu15194161 · Cited by 41
Insights into the molecular underpinning of type 2 diabetes complications
Singh, A., Bocher, O., & Zeggini, E. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddae203 · Cited by 10
Metadata
- Authors
- Soppert, J., Lehrke, M., Marx, N., Jankowski, J., & Noels, H.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2020
- Volume
- 159
- Pages
- 4-33
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W3044870380
- Cited by
- 407
- References
- 445
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.